Afhængigt af responsen af lipidparametrene kan dosis justeres op til 40 mg under nøje lægeligt opsyn) (se afsnit 4. 5).
The MAH was requested to substantiate scientifically the divergent information across member states and justify a proposed common wording, especially with regard to therapeutic daily dose range.